Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation

Pharmaceutical Development and Technology

Volumn 15, Issue 3, 2010, Pages 276-285

  Shah, Punit P ^a,b   Mashru, Rajashree C ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Artemether; Bitter taste masking; Cyclodextrin; Reconstitutable dry suspension

Indexed keywords

ARTEMETHER; BETA CYCLODEXTRIN;

ARTICLE; BITTER TASTE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLOW RATE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; INFRARED SPECTROSCOPY; NORMAL HUMAN; PALATABILITY; PEDIATRICS; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECONSTITUTABLE DRY SUSPENSION; SCANNING ELECTRON MICROSCOPY; SEDIMENTATION; SHELF LIFE; TASTE DISCRIMINATION; VISCOSITY; X RAY POWDER DIFFRACTION;

ARTEMISININS; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SUSPENSIONS; TASTE; VISCOSITY; X-RAY DIFFRACTION;

EID: 77952065112     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903188485     Document Type: Article

References (31)

1. Kayumba PC, Huyghebaert N, Cordella C, Ntawukuliryayo JD, Vervaet C, Remon JP. Quinine sulphate pellets for flexible pediatric drug dosing: Formulation development and evaluation of taste masking efficiency using electronic tongue. Eur J Pharm Biopharm 2007;66:460-465.
2. Kristensen HG, Jorgensen GH, Sonnegaard JM. Mass uniformity of tablets broken by hand. Pharmeuropa 1995;7:298-302.
3. Mc Devitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy 1998;18:193-197.
4. Nahata MC. Pediatric drug formulation: Challenges and potential solutions. Ann Pharmacother 1999;33:247-249.
5. Uchida T, Tanigake A, Miyanaga Y, Matsuyama K, Kunitomo M, Kobayashi Y, Ikezaki H, Taniguchi A. Evaluation of the bitterness of antibiotics using a taste sensor. J Pharm Pharmacol 2003;55:1479-1485. (Pubitemid 37441353)
6. Barra J, Lescure F, Doelker E. Taste masking as a consequence of the organisation of powder mixes. Pharm Acta Helv 1999;74:37-42.
7. Chopra R, Alderborn G, Newton JM, Podezeck F. The influence of film coating on pellet properties. Pharm Dev Tech 2002;7:59-68.
8. Jaskari T, Vuorio M, Kontturi K, Manzanares JA, Hirvonen J. Ionexchange fibers and drugs: An equilibrium study. J Control Rel 2001;70:219-229.
9. Vuorio M, Manzanares JA, Murtomaki L, Hirvonen J, Kankkunen T, Kontturi K. Ion exchange fibers and drugs: A transient study. J Control Rel 2003;91:439-448.
10. Borodkin S, Yunker MH. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. J Pharm Sci 1970;59:481-485.
11. Vyas AH, Bhat CV, Kamath BR, Bafna SL. Cinchona alkaloids on ion-exchange resins V: Ammonium form of resins. J Pharm Sci 1973;62(8):1386-1387.
12. Freudenberg K, Cramer F, Plieninger H. Inclusion compounds of physiologically active organic compounds. German Patent No. 895769;1953.
13. Seiyaku I. Inclusion compounds of tiaramide or its acid addition salts. Japanese Patent No. JP 56061369;1981.
14. Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61:115-125.
15. Shah PP, Mashru RC. Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate. AAPS PharmSciTech 2008;9(3):1025-1030.
16. Hien TT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg 1994;88: S7-8.
17. Hien TT, White NJ. Qinghaosu. Lancet 1993;341:603-608.
18. Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 1992;23:762-767.
19. Yamamoto T, Nagai T, Shimura T, Yasoshima Y. Roles of chemical mediators in taste system. Jpn J Pharmacol 1998;76:325-348.
20. Shah PP, Mashru RC. Development and evaluation of artemether palatable rapid disintegrating tablet with improved dissolution. AAPS PharmSciTech 2008;9(2):492-500.
21. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instr 1965;4:117-212.
22. Shah PP, Mashru RC, Rane, YM, Badhan AC, Takkar AR. Estimation of artemether using simple and rapid spectrophotometric method for routine analysis. J Pharm Res 2007;6(4):253-254.
23. Shah PP, Mashru RC, Takkar AR, Badhan AC. Effect of chitosan crosslinking on bitterness of artemether microparticles using response surface methodology. J Pharm Pharmacol 2008;60(4):421-427.
24. Shah PP, Mashru RC, Rane, YM, Badhan AC. Design and optimization of artemether microparticles for bitter taste masking. Acta Pharm 2008;58(4):379-392.
25. Li N, Zhang Y-H, Wu Y-N, Xiong X-L, Zhang Y-H. Inclusion complex of trimethoprim with beta-cyclodextrin. J Pharm Biomed Anal 2005;39:824-829.
26. Mielcarek J, Czernielewska A, Czarczynska B. Inclusion complexes of felodipine and amlodipine with methyl-betacyclodextrin. J Inclus Phenom Macro Chem 2006;54:17-21.
27. Mura P, Faucci MT, maestrelli F, Furlanetto S, Pinzauti S. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. J Pharm Biomed Anal 2002;29:1015-1024.
28. Naidu NB, Chowdary KPR, Murthy KVR, Satyananarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J Pharm Biomed Anal 2004;35:75-86.
29. Otero-Espinar FJ, Anguiano-Igea S, Gonzalez NG, Vila-Jato JL, Blanco-Mendez J. Oral bioavailability of naproxen-bcyclodextrin inclusion compound. Int J Pharm 1991;75:37-44.
30. Tyle P, Kuenn C, Geier L, Jerosz P. Effect of size, shape and hardness of particles in suspension on oral palatability. Drug Dev Ind Pharm 1990;16(8):1339-1364.
31. Kittipongpatana OS, Sirithunyalug J. Development of suspending agent from sodium carboxymethyl mungbean starches. Drug Dev Ind Pharm 2006;32:809-820. (Pubitemid 44266765)